These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 7708765

  • 1. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
    Zhou X, Berglund P, Zhao H, Liljeström P, Jondal M.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):3009-13. PubMed ID: 7708765
    [Abstract] [Full Text] [Related]

  • 2. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.
    Vignuzzi M, Gerbaud S, van der Werf S, Escriou N.
    J Gen Virol; 2001 Jul 28; 82(Pt 7):1737-1747. PubMed ID: 11413386
    [Abstract] [Full Text] [Related]

  • 3. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice.
    Berglund P, Fleeton MN, Smerdou C, Liljeström P.
    Vaccine; 1999 Feb 05; 17(5):497-507. PubMed ID: 10073729
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Infection of cultured murine brain cells by Semliki Forest virus: effects of interferon-alpha beta on viral replication, viral antigen display, major histocompatibility complex antigen display and lysis by cytotoxic T lymphocytes.
    Morris A, Tomkins PT, Maudsley DJ, Blackman M.
    J Gen Virol; 1987 Jan 05; 68 ( Pt 1)():99-106. PubMed ID: 3492589
    [Abstract] [Full Text] [Related]

  • 6. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
    Lawson CM, Bennink JR, Restifo NP, Yewdell JW, Murphy BR.
    J Virol; 1994 Jun 05; 68(6):3505-11. PubMed ID: 7514677
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.
    Anderson RW, Bennink JR, Yewdell JW, Maloy WL, Coligan JE.
    Mol Immunol; 1992 Sep 05; 29(9):1089-96. PubMed ID: 1495499
    [Abstract] [Full Text] [Related]

  • 9. Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
    Huckriede A, Bungener L, Holtrop M, de Vries J, Waarts BL, Daemen T, Wilschut J.
    Vaccine; 2004 Mar 12; 22(9-10):1104-13. PubMed ID: 15003637
    [Abstract] [Full Text] [Related]

  • 10. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A, Walczak M, Regts J, Rots MG, Kamps G, Dontje B, Haisma HY, Wilschut J, Daemen T.
    Gene Ther; 2007 Dec 12; 14(24):1695-704. PubMed ID: 17928874
    [Abstract] [Full Text] [Related]

  • 11. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA, Donoso G, Moraga-Cid G, Folch H, Céspedes S, Andrews E.
    Infect Immun; 2005 Jun 12; 73(6):3294-300. PubMed ID: 15908354
    [Abstract] [Full Text] [Related]

  • 12. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.
    Fernández IM, Snijders A, Benaissa-Trouw BJ, Harmsen M, Snippe H, Kraaijeveld CA.
    J Virol; 1993 Oct 12; 67(10):5843-8. PubMed ID: 7690411
    [Abstract] [Full Text] [Related]

  • 13. Induction of CD8+ cytotoxic T cells by immunization with killed influenza virus and effect of cholera toxin B subunit.
    Mbawuike IN, Wyde PR.
    Vaccine; 1993 Sep 12; 11(12):1205-13. PubMed ID: 7903015
    [Abstract] [Full Text] [Related]

  • 14. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V, Villefroy P, Godfrin D, Pavirani A, Venet A, Guillet JG.
    Eur J Immunol; 1995 Dec 12; 25(12):3467-73. PubMed ID: 8566039
    [Abstract] [Full Text] [Related]

  • 15. Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition.
    de Mare A, Lambeck AJ, Regts J, van Dam GM, Nijman HW, Snippe H, Wilschut J, Daemen T.
    Gene Ther; 2008 Mar 12; 15(6):393-403. PubMed ID: 18004406
    [Abstract] [Full Text] [Related]

  • 16. Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.
    Daemen T, Riezebos-Brilman A, Regts J, Dontje B, van der Zee A, Wilschut J.
    Antivir Ther; 2004 Oct 12; 9(5):733-42. PubMed ID: 15535411
    [Abstract] [Full Text] [Related]

  • 17. Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.
    Kulkarni AB, Morse HC, Bennink JR, Yewdell JW, Murphy BR.
    J Virol; 1993 Jul 12; 67(7):4086-92. PubMed ID: 7685408
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK, Nahill SR, Welsh RM.
    J Exp Med; 1994 Jun 01; 179(6):1933-43. PubMed ID: 8195718
    [Abstract] [Full Text] [Related]

  • 20. Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.
    Daemen T, Riezebos-Brilman A, Bungener L, Regts J, Dontje B, Wilschut J.
    Vaccine; 2003 Mar 07; 21(11-12):1082-8. PubMed ID: 12559783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.